OR8A2P

Across TCGA pan-cancer cohorts, OR8A2P RNA differs between tumor and matched normal tissue in 2 of 18 cancer types tested, making tumor–normal expression one of OR8A2P’s most consistent transcriptional readouts.

The strongest signal is observed in kidney renal papillary cell carcinoma (KIRP), where OR8A2P RNA is more highly expressed in tumor relative to normal tissue. In most cancer types OR8A2P is over-expressed in tumor.

KIRP and BRCA are the cancer types where OR8A2P tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in OR8A2P RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
KIRP	All	All	+0.030	.002	2	view →
BRCA	All	All	+0.022	.043	2	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 2 strongest of 2 lineages.

OR8A2P–KIRP

Open the KIRP breakdown →